Healthcare Interoperability Solutions - Global ﾂ鮓ｹﾔｭｴｴ Outlook (2017-2026)

Publication ID:

SMRC0319003

Publication Date:

March 1, 2019

Pages:

164

Publisher:

Stratistics MRC

Countries:

Global [1]

USD 4,150.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ is accounted for $1.81 billion in 2017 and is expected to reach $6.04 billion by 2026 growing at a CAGR of 14.4%. Factors such as increasing focus on patient-centric care delivery and government funding for healthcare interoperability are fueling market growth. However, the lack of consistent data and true interoperability solutions are a hindrance for the growth of the market. Moreover, an increase in the development of healthcare infrastructure in emerging markets acts as growth opportunities for the market.

Healthcare systems are pursuing to leverage their investment in electronic health record (EHR) systems by integrating them with other critical technology. Through this need comes the need for healthcare interoperability solutions. Healthcare interoperability solutions are used in order to overcome the complexity of healthcare domain, these solutions allow data sharing and re-uses among disparate healthcare applications and devices, involves the reduction of healthcare expenses and the enhancement in the quality of care.

Based on the type, services segment fuels the market share during the forecast period. This segment can be attributed to the shifting era towards cloud computing and reduced operational costs for faster and better performance of business processes and applications. By geography, North America region is anticipated to grow due to the rising demand for quality healthcare delivery, the need to curb increasing healthcare expenditure, and the implementation of favorable initiatives & regulations to improve the overall efficiency of healthcare organizations.

Some of the key players in Healthcare Interoperability Solutions market include Nextgen Healthcare, Inc., Allscripts Healthcare Solutions, Inc., Jitterbit, Interfaceware Inc., Intersystems Corporation, Cerner Corporation, Koninklijke Philips NV, EPIC Systems Corporation, Orion Health Group Limited, Visolve Inc., and Infor, Inc.

Interoperability Levels Covered:
窶｢ Structural Interoperability
窶｢ Semantic Interoperability
窶｢ Foundational Interoperability

Softwares Covered:
窶｢ Integrated Software
窶｢ Standalone Software

Types Covered:
窶｢ Services
窶｢ Software Solutions

End Users Covered:
窶｢ Pharmacies
窶｢ Healthcare Payers
窶｢ Healthcare Providers

Regions Covered:
窶｢ North America
o US
o Canada
o Mexico
窶｢ Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
窶｢ Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
窶｢ South America
o Argentina
o Brazil
o Chile
o Rest of South America
窶｢ Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- ﾂ鮓ｹﾔｭｴｴ share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- ﾂ鮓ｹﾔｭｴｴ forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- ﾂ鮓ｹﾔｭｴｴ Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter窶冱 five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
窶｢ Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
窶｢ Regional Segmentation
o ﾂ鮓ｹﾔｭｴｴ estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
窶｢ Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table Of Contents:

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 ﾂ鮓ｹﾔｭｴｴ Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging ﾂ鮓ｹﾔｭｴｴs
3.8 Futuristic ﾂ鮓ｹﾔｭｴｴ Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ, By Interoperability Level
5.1 Introduction
5.2 Structural Interoperability
5.3 Semantic Interoperability
5.4 Foundational Interoperability

6 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ, By Software
6.1 Introduction
6.2 Integrated Software
6.3 Standalone Software

7 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ, By Type
7.1 Introduction
7.2 Services
7.3 Software Solutions
7.3.1 Healthcare Information Exchange Interoperability Solutions
7.3.2 Lab System Interoperability Solutions
7.3.3 Enterprise Interoperability Solutions
7.3.4 EHR Interoperability Solutions
7.3.5 Imaging System Interoperability Solutions
7.3.6 Other Interoperability Solutions

8 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ, By End User
8.1 Introduction
8.2 Pharmacies
8.3 Healthcare Payers
8.4 Healthcare Providers
8.4.1 Long-Term Care Centers
8.4.2 Diagnostic and Imaging Centers
8.4.3 Hospitals and Clinics
8.4.4 Other Providers

9 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Nextgen Healthcare, Inc.
11.2 Allscripts Healthcare Solutions, Inc.
11.3 Jitterbit
11.4 Interfaceware Inc.
11.5 Intersystems Corporation
11.6 Cerner Corporation
11.7 Koninklijke Philips NV `
11.8 EPIC Systems Corporation
11.9 Orion Health Group Limited
11.10 Visolve Inc.
11.11 Infor, Inc.

List of Tables
1 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Region (2016-2026) ($MN)
2 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Interoperability Level (2016-2026) ($MN)
3 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Structural Interoperability (2016-2026) ($MN)
4 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Semantic Interoperability (2016-2026) ($MN)
5 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Foundational Interoperability (2016-2026) ($MN)
6 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Software (2016-2026) ($MN)
7 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Integrated Software (2016-2026) ($MN)
8 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Standalone Software (2016-2026) ($MN)
9 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Type (2016-2026) ($MN)
10 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Services (2016-2026) ($MN)
11 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Software Solutions (2016-2026) ($MN)
12 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Information Exchange Interoperability Solutions (2016-2026) ($MN)
13 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Lab System Interoperability Solutions (2016-2026) ($MN)
14 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Enterprise Interoperability Solutions (2016-2026) ($MN)
15 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By EHR Interoperability Solutions (2016-2026) ($MN)
16 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Imaging System Interoperability Solutions (2016-2026) ($MN)
17 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Other Interoperability Solutions (2016-2026) ($MN)
18 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By End User (2016-2026) ($MN)
19 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Pharmacies (2016-2026) ($MN)
20 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Payers (2016-2026) ($MN)
21 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Providers (2016-2026) ($MN)
22 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Long-Term Care Centers (2016-2026) ($MN)
23 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Diagnostic and Imaging Centers (2016-2026) ($MN)
24 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Hospitals and Clinics (2016-2026) ($MN)
25 Global Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Other Providers (2016-2026) ($MN)
26 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Country (2016-2026) ($MN)
27 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Interoperability Level (2016-2026) ($MN)
28 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Structural Interoperability (2016-2026) ($MN)
29 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Semantic Interoperability (2016-2026) ($MN)
30 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Foundational Interoperability (2016-2026) ($MN)
31 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Software (2016-2026) ($MN)
32 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Integrated Software (2016-2026) ($MN)
33 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Standalone Software (2016-2026) ($MN)
34 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Type (2016-2026) ($MN)
35 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Services (2016-2026) ($MN)
36 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Software Solutions (2016-2026) ($MN)
37 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Information Exchange Interoperability Solutions (2016-2026) ($MN)
38 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Lab System Interoperability Solutions (2016-2026) ($MN)
39 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Enterprise Interoperability Solutions (2016-2026) ($MN)
40 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By EHR Interoperability Solutions (2016-2026) ($MN)
41 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Imaging System Interoperability Solutions (2016-2026) ($MN)
42 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Other Interoperability Solutions (2016-2026) ($MN)
43 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By End User (2016-2026) ($MN)
44 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Pharmacies (2016-2026) ($MN)
45 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Payers (2016-2026) ($MN)
46 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Providers (2016-2026) ($MN)
47 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Long-Term Care Centers (2016-2026) ($MN)
48 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Diagnostic and Imaging Centers (2016-2026) ($MN)
49 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Hospitals and Clinics (2016-2026) ($MN)
50 North America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Other Providers (2016-2026) ($MN)
51 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Country (2016-2026) ($MN)
52 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Interoperability Level (2016-2026) ($MN)
53 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Structural Interoperability (2016-2026) ($MN)
54 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Semantic Interoperability (2016-2026) ($MN)
55 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Foundational Interoperability (2016-2026) ($MN)
56 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Software (2016-2026) ($MN)
57 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Integrated Software (2016-2026) ($MN)
58 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Standalone Software (2016-2026) ($MN)
59 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Type (2016-2026) ($MN)
60 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Services (2016-2026) ($MN)
61 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Software Solutions (2016-2026) ($MN)
62 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Information Exchange Interoperability Solutions (2016-2026) ($MN)
63 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Lab System Interoperability Solutions (2016-2026) ($MN)
64 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Enterprise Interoperability Solutions (2016-2026) ($MN)
65 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By EHR Interoperability Solutions (2016-2026) ($MN)
66 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Imaging System Interoperability Solutions (2016-2026) ($MN)
67 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Other Interoperability Solutions (2016-2026) ($MN)
68 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By End User (2016-2026) ($MN)
69 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Pharmacies (2016-2026) ($MN)
70 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Payers (2016-2026) ($MN)
71 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Providers (2016-2026) ($MN)
72 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Long-Term Care Centers (2016-2026) ($MN)
73 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Diagnostic and Imaging Centers (2016-2026) ($MN)
74 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Hospitals and Clinics (2016-2026) ($MN)
75 Europe Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Other Providers (2016-2026) ($MN)
76 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Country (2016-2026) ($MN)
77 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Interoperability Level (2016-2026) ($MN)
78 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Structural Interoperability (2016-2026) ($MN)
79 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Semantic Interoperability (2016-2026) ($MN)
80 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Foundational Interoperability (2016-2026) ($MN)
81 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Software (2016-2026) ($MN)
82 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Integrated Software (2016-2026) ($MN)
83 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Standalone Software (2016-2026) ($MN)
84 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Type (2016-2026) ($MN)
85 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Services (2016-2026) ($MN)
86 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Software Solutions (2016-2026) ($MN)
87 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Information Exchange Interoperability Solutions (2016-2026) ($MN)
88 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Lab System Interoperability Solutions (2016-2026) ($MN)
89 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Enterprise Interoperability Solutions (2016-2026) ($MN)
90 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By EHR Interoperability Solutions (2016-2026) ($MN)
91 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Imaging System Interoperability Solutions (2016-2026) ($MN)
92 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Other Interoperability Solutions (2016-2026) ($MN)
93 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By End User (2016-2026) ($MN)
94 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Pharmacies (2016-2026) ($MN)
95 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Payers (2016-2026) ($MN)
96 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Providers (2016-2026) ($MN)
97 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Long-Term Care Centers (2016-2026) ($MN)
98 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Diagnostic and Imaging Centers (2016-2026) ($MN)
99 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Hospitals and Clinics (2016-2026) ($MN)
100 Asia Pacific Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Other Providers (2016-2026) ($MN)
101 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Country (2016-2026) ($MN)
102 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Interoperability Level (2016-2026) ($MN)
103 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Structural Interoperability (2016-2026) ($MN)
104 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Semantic Interoperability (2016-2026) ($MN)
105 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Foundational Interoperability (2016-2026) ($MN)
106 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Software (2016-2026) ($MN)
107 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Integrated Software (2016-2026) ($MN)
108 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Standalone Software (2016-2026) ($MN)
109 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Type (2016-2026) ($MN)
110 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Services (2016-2026) ($MN)
111 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Software Solutions (2016-2026) ($MN)
112 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Information Exchange Interoperability Solutions (2016-2026) ($MN)
113 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Lab System Interoperability Solutions (2016-2026) ($MN)
114 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Enterprise Interoperability Solutions (2016-2026) ($MN)
115 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By EHR Interoperability Solutions (2016-2026) ($MN)
116 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Imaging System Interoperability Solutions (2016-2026) ($MN)
117 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Other Interoperability Solutions (2016-2026) ($MN)
118 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By End User (2016-2026) ($MN)
119 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Pharmacies (2016-2026) ($MN)
120 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Payers (2016-2026) ($MN)
121 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Providers (2016-2026) ($MN)
122 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Long-Term Care Centers (2016-2026) ($MN)
123 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Diagnostic and Imaging Centers (2016-2026) ($MN)
124 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Hospitals and Clinics (2016-2026) ($MN)
125 South America Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Other Providers (2016-2026) ($MN)
126 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Country (2016-2026) ($MN)
127 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Interoperability Level (2016-2026) ($MN)
128 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Structural Interoperability (2016-2026) ($MN)
129 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Semantic Interoperability (2016-2026) ($MN)
130 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Foundational Interoperability (2016-2026) ($MN)
131 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Software (2016-2026) ($MN)
132 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Integrated Software (2016-2026) ($MN)
133 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Standalone Software (2016-2026) ($MN)
134 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Type (2016-2026) ($MN)
135 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Services (2016-2026) ($MN)
136 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Software Solutions (2016-2026) ($MN)
137 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Information Exchange Interoperability Solutions (2016-2026) ($MN)
138 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Lab System Interoperability Solutions (2016-2026) ($MN)
139 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Enterprise Interoperability Solutions (2016-2026) ($MN)
140 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By EHR Interoperability Solutions (2016-2026) ($MN)
141 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Imaging System Interoperability Solutions (2016-2026) ($MN)
142 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Other Interoperability Solutions (2016-2026) ($MN)
143 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By End User (2016-2026) ($MN)
144 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Pharmacies (2016-2026) ($MN)
145 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Payers (2016-2026) ($MN)
146 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Healthcare Providers (2016-2026) ($MN)
147 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Long-Term Care Centers (2016-2026) ($MN)
148 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Diagnostic and Imaging Centers (2016-2026) ($MN)
149 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Hospitals and Clinics (2016-2026) ($MN)
150 Middle East & Africa Healthcare Interoperability Solutions ﾂ鮓ｹﾔｭｴｴ Outlook, By Other Providers (2016-2026) ($MN)

Companies Mentioned:

Nextgen Healthcare, Inc.
Allscripts Healthcare Solutions, Inc.
Jitterbit
Interfaceware Inc.
Intersystems Corporation
Cerner Corporation
Koninklijke Philips NV
EPIC Systems Corporation
Orion Health Group Limited
Visolve Inc.
Infor, Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

ﾌ�

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

ﾌ�

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.